Clinical outcome and quality of life of lacrimal sac mucocele treated via endoscopic posterior approach.

Abstract

OBJECTIVE\nDacryocystorhinostomy (DCR) is the surgical treatment for lacrimal sac mucoceles (LSM), yet variants of the procedure are several. Since LSM causes bone remodeling and thinning, especially of the lacrimal bone, osteotomy at that site is reasonably the easiest. The aim of the study is to support treatment of LSM via a posterior DCR approach, in a large cohort of cases, and report patients quality of life after the procedure with validated questionnaires.\n\n\nMETHODS\nSingle-center observational retrospective study on a specific methodology (endoscopic-DCR via posterior approach). Consecutive patients with LSM were enrolled in 2008-2020; CT scans were reviewed, bone thickness was measured bilaterally and compared. Resolution of mucocele, epiphora and infection were analyzed after 6-months. Patients were administered the Munk Score and Lacrimal Symptom Questionnaire (Lac-Q). Statistical analysis was done to compare bone thickness between the two sides; descriptive analysis of the questionnaires results was presented.\n\n\nRESULTS\nForty-four patients with LSM were enrolled. The LSM side showed frontal process thickness of 4.00\xa0±\xa01.06\xa0mm (vs 3.90\xa0±\xa01.03 on the unaffected side; p\xa0=\xa00.23) and a lacrimal bone of 0.32\xa0±\xa00.12\xa0mm (vs 0.41\xa0±\xa00.12; p\xa0<\xa00.001). Resolution of infection was achieved in 97.4% cases, anatomical patency in 87.2%. After 5\xa0years, 84.6% of patients reported no relevant epiphora (Munk score 0-1). Social impact (Lac-Q) due to lacrimal malfunctioning was still noted in 30.8% patients.\n\n\nCONCLUSIONS\nAdult LSM is a rare condition and DCR remains the mainstay of treatment. LSM physiopathology may support a preferred surgical choice via a posterior approach. Despite objective patency, some lacrimal way malfunctioning may be experienced in a minority of cases.